News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Horizon Europe WP 2023-2024 - Call Topics Overview & Update Domain pages and Info days
Published on | 2 years ago
Programmes MSCA RI Health Culture and society Security Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment Joint Research Center EIC EIE Widening/Spreading Enhancing EU R&I Missions New European Bauhaus Horizon Europe HorizonEU L+FNCP Flanders informed you of the adoption of the Horizion Europe 2023-2024 Work Programme and publication on the EU Funding & Tenders Portal.
NCP Flanders offers on its website a handy, up-to-date Call Topics Overview, a weekly updated Excel file which enables you to quickly find back relevant call topic information.
The domain specific pages of the NCP Flanders website have also been updated. For each of the Horizon Europe subprogrammes, the Work Programme and open/forthcoming calls are now also accessible via our pages:
- Pillar I - Marie Sklodowska-Curie Actions
- Pillar I - Research Infrastructures
- Pillar II - Cluster 1 Health
- Pillar II - Cluster 2 Culture and Society
- Pillar II - Cluster 3 - Security
- Pillar II - Cluster 4 - Digital, Industry, Space
- Pillar II - Cluster 5 - Climate, Energy, Mobility
- Pillar II - Cluster 6 - Agro-food, Evironment
- Pillar III - Eurpean Innovation Ecosystems
- Pillar III - European Innovation Council (WP 2023 available though not yet in EU Funding & Tenders Portal)
- Widening participation & Spreading Excellence
- Reforming & Enhancing the European R&I System
- EU Missions
NCP Flanders has also updated the information on the upcoming Horizon Europe Info Days organised by the Commission and on Brokerage events. You can find the latest information in our event calendar and an overview of all events here below:
- Research Infrastructures (Pillar I): Info day on 6 December - Rewatch
- Cluster 1: Info Day on 19 January 2023; Brokerage event on 20 January 2023 (incl. Cancer Mission)
- Cluster 2: Info day on 17 January 2023; Brokerage event on 18-19 January 2023
- Cluster 4: Info days on 12-14 December; Brokerage events on 8, 14 and 15-16 December
- Cluster 5: Info days on 15-16 December; Brokerage event on 15 December
- Cluster 6: Info days on 13-14 December; Brokerage event on 19 December
- European Innovation Council: Info day on 13 December
- Widening & European Research Area (ERA) actions: Info day on 12 December and Brokerage event (ERA) on 19 December
- EU Missions: Info Days on 17-18 January 2023 (TBC)
Related News
|
2024-12-13
|
2 days ago |
BioAgora Open Call: Science - Policy - Society Interface (SPSI) capacity development... |
|
2024-12-12
|
3 days ago |
EP PerMed - New Fast Track and Venture Creator Programmes |
|
2024-12-12
|
3 days ago |
Update: AGRARIAN Call #1 is now open |
|
2024-12-10
|
5 days ago |
ERDERA - 2025 Call on pre-clinical therapy studies for rare diseases open |
|
2024-12-10
|
5 days ago |
STARHAUS Open Calls on Open Innovation and Creativity |
|
2024-12-09
|
6 days ago |
SpongeWorks Open Call |
|
2024-12-09
|
6 days ago |
Innovation Prize Open Call - GOBEYOND |
|
2024-12-09
|
6 days ago |
Looking for Virtual World - Metaverse - Extended Reality Initiatives |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1502 articles available search in articlesTestimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
